User:Mr. Ibrahem/Abemaciclib

Abemaciclib, sold under the brand names Verzenio among others, is a medication used to treat breast cancer. Specifically it is used for advanced cases that are HR positive but HER2 negative. It is taken by mouth.

Common side effects include diarrhea, low white blood cells, nausea, infections, tiredness, hair loss, and low platelets. Other side effects may include pneumonitis, liver problems, and blood clots. Use in pregnancy may harm the baby. It is a CDK inhibitor which blocks the activity of CDK4 and CDK6.

Abemaciclib was approved for medical use in the United States in 2017 and Europe in 2018. In the United Kingdom 4 weeks costs the NHS about £2,950 as of 2021. In the United States this amount costs about 13,700 USD.